Advertisement

Annals of Vascular Surgery

, Volume 3, Issue 3, pp 248–250 | Cite as

Monoclonal antibody immunoassay in the study of thrombogenicity of preclotted and gelatin-impregnated aortic prostheses

  • H. A. Zahrani
  • R. J. Cuschieri
  • G. D. O. Lowe
  • J. T. Douglas
  • J. G. Pollock
Original Articles
  • 5 Downloads

Abstract

Peripheral Vascular Surgery Unit and University Department of Medicine (Hemostasis and Thrombosis Research Unit), Glasgow Royal Infirmary 16 Alexandra Parade, Glasgow, Scotland. The Dimertest Enzyme Immunoassay has been used to compare the degree of thrombogenicity of the standard knitted Dacron prosthesis (n = 10) and the gelatin-impregnated Dacron prosthesis (n = 10) after infrarenal aortic reconstruction. After surgery there was a similar rise in cross-linked fibrin degradation products with both types of prostheses. Although on the third day the D-Dimer level in the gelatin-impregnated prosthesis was lower, there was no significant difference in the D-Dimer level at six weeks. This suggests that the potential risk of thrombogenicity in the gelatin-impregnated prosthesis is similar to the standard preclotted type.

Key Words

Thrombogenicity vascular prosthesis fibrin degradation products Dimertest Immunoassay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    RHODES RS, HUTTON MC, LALKA SG. Reoperation for intra-abdominal vascular disease. In: FRY DE (ed). Reoperative surgery of the abdomen. New York: Marcel Dekker, 1986; 152–247.Google Scholar
  2. 2.
    NEVELSTEEN A, SUY R, DAEMEN W, BOEL A, STALPAERT G. Aortofemoral grafting: factors influencing late results.Surgery 1980:88:642–653.PubMedGoogle Scholar
  3. 3.
    ELMS MJ, BUNCE IH, BUNDESEN PG, DBRYLATT DB, WEBBER AJ, MASCI PP, WHITAKER AN. Measurement of crosslinked fibrin degradation products. An immunoassay using monoclonal antibodies.Thromb Haemostus 1983;50:591–594.Google Scholar
  4. 4.
    WHITAKER AN, ELMS MJ, MASCI PP, BUNZESEN PG, DBRYLATT DB, WEBBER AJ, BUNCE IH. Measurements of crosslinked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.Am J Clin Patho 1984;57: 882–887.CrossRefGoogle Scholar
  5. 5.
    ROWBOTHAN BJ, CARROLL P, WHITAKER AN. Measurement of crosslinked fibrin degradation products. An immunoassay using monoclonal antibodies.Thromb Haemostus 1983:50: 591–594.Google Scholar
  6. 6.
    WHITEHOUSE WM, ZELENOCK GB, WAKEFIELD TW. Functional assessment of- implanted vascular grafts utilizing radionuclide imaging. In: STANLEY JC, (eds). Biological and synthetic vascular prostheses. New York: Grune and Stratton, 1982;153–247.Google Scholar
  7. 7.
    GAFFNEY PJ. The occurrence and clinical relevance of fibrin fragments in blood.Ann NY Acad Sci 1983;408: 407–4355.CrossRefPubMedGoogle Scholar
  8. 8.
    WHITAKER AN, MASCI PP, ROWBOTHAN BJ, CARROLL P, REASBECK P, GUERRINI SM, McCASSREY J, LEE K, ELMS MJ, GUNT D, WEBBER AJ, Reit. Applications of plasma assays of crosslinked fibrin degradation products (XLFDP) and the diagnosis of thrombo-embolic disease. In: Lowe GDO, et al (eds). Fibrinogen 2: biochemistry, physiology and clinical relevance. Amsterdam: Elsevier Science Publishers BV, 1987;205–208.Google Scholar
  9. 9.
    NIEUWENHUIZEN W. Plasma assays of fibrinogen/fibrin degradation products and their clinical relevance. In: LOWE GDO, NIEUWENHUIZEN W. (eds). Fibrinogen 2: biochemistry, physiology and clinical relevance. Amsterdam: Elsevier Science Publishers BV, 1987;173–179.Google Scholar
  10. 10.
    DRURY JK, ASHTON TR, CUNNINGHAM JD, MAINI R, POLLOCK JG. Experimental and clinical experience with a gelatin-impregnated Dacron prosthesis.Ann Vasc Surg 1987;1:542–547.CrossRefPubMedGoogle Scholar
  11. 11.
    McCOLLUM CN, KESTER RC, RAJAH SM, LEAROYD P, PEPPER N. Arterial graft maturation: the duration of thrombotic activity in Dacron aorto-bifemoral grafts measured by platelet and fibrinogen kinetics.Br J Surg 1982;68:61–64.CrossRefGoogle Scholar
  12. 12.
    DeBAKEY ME, JORDAN GL, BEALL AG, NEVEL-STEEN A, SUY R, DAENEN W, BOEL A, STALPAERT G. Basic biologic reactions to vascular graft and prosthesis.Surg Clin North Am 1965;45:477–496.PubMedGoogle Scholar
  13. 13.
    YATES SG, BARROS D’SA AAB, BERGER K, FERNANDEZ LG, WOOD SJ, RITTENHOUSE EA, MANSS-FIELD PB, SAUVAGE LR. The preclotting of porous arterial prostheses.Ann Surg 1978;188:611–622.CrossRefPubMedGoogle Scholar
  14. 14.
    BIBBY SR, CROW MJ, SHEEHAM SJ. Should preclotted Dacron grafts still be used?Br J Surg (in press).Google Scholar

Copyright information

© Annals of Vascular Surgery Inc. 1989

Authors and Affiliations

  • H. A. Zahrani
    • 1
    • 2
  • R. J. Cuschieri
    • 1
    • 2
  • G. D. O. Lowe
    • 1
    • 2
  • J. T. Douglas
    • 1
    • 2
  • J. G. Pollock
    • 1
    • 2
  1. 1.Peripheral Vascular Surgery UnitGlasgow Royal InfirmaryGlasgowScotland
  2. 2.University Department of Medicine (Hemostasis and Thrombosis Research Unit)Glasgow Royal InfirmaryGlasgowScotland

Personalised recommendations